↓ Skip to main content

PARP Inhibitors in Ovarian Cancer: A Review

Overview of attention for article published in Targeted Oncology, June 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 611)
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
8 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PARP Inhibitors in Ovarian Cancer: A Review
Published in
Targeted Oncology, June 2023
DOI 10.1007/s11523-023-00970-w
Pubmed ID
Authors

David M. O’Malley, Thomas C. Krivak, Nashwa Kabil, Jiefen Munley, Kathleen N. Moore

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 7 14%
Researcher 5 10%
Student > Master 4 8%
Student > Doctoral Student 3 6%
Student > Ph. D. Student 3 6%
Other 8 16%
Unknown 19 39%
Readers by discipline Count As %
Unspecified 7 14%
Medicine and Dentistry 7 14%
Biochemistry, Genetics and Molecular Biology 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Materials Science 2 4%
Other 7 14%
Unknown 18 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2024.
All research outputs
#4,124,540
of 25,320,147 outputs
Outputs from Targeted Oncology
#47
of 611 outputs
Outputs of similar age
#69,100
of 374,680 outputs
Outputs of similar age from Targeted Oncology
#2
of 11 outputs
Altmetric has tracked 25,320,147 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 611 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,680 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.